Riskpilot← Back to searchSign inGet full accessNC-konsult AB
ABActiveOrg 5590278205Sållargatan 4Medical specialists activities · NACE 8622Est. 20152 employees
Revenue 2025
SEK 2,9M
-16% vs 2024
EBITDA margin
33.2%
-32% vs 2024
Equity ratio
45.6%
Financial strength
Net profit 2025
SEK 804K
-14% vs 2024
| Revenue | SEK 2,9M | -16% |
| EBITDA | SEK 955K | -32% |
| Net profit | SEK 804K | -14% |
| Total assets | SEK 7,4M | +4% |
| Equity | SEK 3,4M | +6% |
| Employees | 2 | — |
Legal name
NC-konsult AB
Org number
5590278205
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 september 2015
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet skall uthyra specialistläkare i psykiatri både i sluten- och öppenvård.
Address
Sållargatan 4
Email
normunds.cirulis@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 762 | 3 600 | 3 654 | 3 417 | 2 881 |
| Staff expenses | — | −1 491 | −1 692 | −1 527 | −1 375 |
| EBITDA | 1 731 | 1 457 | 1 431 | 1 399 | 955 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 1 731 | 1 457 | 1 431 | 1 399 | 955 |
| Net financials | — | 4 | −50 | 130 | 117 |
| Profit before tax | 1 294 | 1 184 | 1 163 | 1 262 | 1 024 |
| Tax | −270 | −326 | −290 | −322 | −220 |
| Net profit | 1 024 | 858 | 873 | 940 | 804 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 506 | 5 288 | 6 148 | 7 118 | 7 403 |
| Equity | 2 049 | 2 207 | 2 630 | 3 170 | 3 374 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 436 | 453 | 491 | 475 | 447 |
| Total debt | 436 | 453 | 491 | 475 | 447 |
EBITDA margin
33.2%
This company
15.8%
Market median
+110% vs market
20212025
Equity ratio
45.6%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
23.8%
This company
18.4%
Market median
+29% vs market
20212025
Net profit margin
27.9%
This company
8.1%
Market median
+244% vs market
20212025
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20212025
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GB Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NC-konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Goran Bahmani Komasi | Audit | 0 companies |
| Normunds Cirulis | Board of Directors | 0 companies |
| Janis Rozenbergs | Deputy Board Member | 0 companies |